- Home
- YALA vs ICUCW Comparison
YALA vs ICUCW Comparison
Compare YALA & ICUCW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- YALA
- ICUCW
- Stock Information
- Founded
- YALA 2016
- ICUCW N/A
- Country
- YALA United Arab Emirates
- ICUCW United States
- Employees
- YALA N/A
- ICUCW 12
- Industry
- YALA Computer Software: Programming Data Processing
- ICUCW Biotechnology: Pharmaceutical Preparations
- Sector
- YALA Technology
- ICUCW Health Care
- Exchange
- YALA Nasdaq
- ICUCW Nasdaq
- Market Cap
- YALA N/A
- ICUCW N/A
- IPO Year
- YALA 2020
- ICUCW 2021
- Fundamental
- Price
- YALA $6.56
- ICUCW $0.04
- Analyst Decision
- YALA
- ICUCW
- Analyst Count
- YALA 0
- ICUCW 0
- Target Price
- YALA N/A
- ICUCW N/A
- AVG Volume (30 Days)
- YALA 970.7K
- ICUCW N/A
- Earning Date
- YALA 05-19-2025
- ICUCW N/A
- Dividend Yield
- YALA N/A
- ICUCW N/A
- EPS Growth
- YALA 13.85
- ICUCW N/A
- EPS
- YALA 0.74
- ICUCW N/A
- Revenue
- YALA $339,675,845.00
- ICUCW N/A
- Revenue This Year
- YALA $9.21
- ICUCW N/A
- Revenue Next Year
- YALA $5.98
- ICUCW N/A
- P/E Ratio
- YALA $8.86
- ICUCW N/A
- Revenue Growth
- YALA 6.52
- ICUCW N/A
- 52 Week Low
- YALA $3.71
- ICUCW N/A
- 52 Week High
- YALA $6.65
- ICUCW N/A
- Technical
- Relative Strength Index (RSI)
- YALA 75.99
- ICUCW N/A
- Support Level
- YALA $6.00
- ICUCW N/A
- Resistance Level
- YALA $6.64
- ICUCW N/A
- Average True Range (ATR)
- YALA 0.40
- ICUCW 0.00
- MACD
- YALA 0.10
- ICUCW 0.00
- Stochastic Oscillator
- YALA 95.61
- ICUCW 0.00
About ICUCW SeaStar Medical Holding Corporation Warrant
SeaStar Medical Holding Corp is a medical technology company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs. It is developing and commercializing extracorporeal therapies that target the effector cells that drive systemic inflammation, causing direct tissue damage and secreting a range of pro-inflammatory cytokines that initiate and propagate imbalanced immune responses.